Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of CareBusiness Wire • 05/01/23
Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe DiseaseBusiness Wire • 05/01/23
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.GlobeNewsWire • 04/26/23
Sanofi Announces Launch of AVAXIM® Junior in the UK for Active Immunisation Against Infection Caused by the Hepatitis A Virus in Children Aged 12 Months to 15 YearsBusiness Wire • 04/23/23
Senate legislation would cap insulin at $35 per month for people with private insuranceCNBC • 04/21/23
5 European Dividend Aristocrats Offer Huge Growth and Income Potential With Diversification From the US24/7 Wall Street • 04/13/23
Why 7 of the Highest-Yielding ‘Strong Buy' Health Care Stocks Are the Absolute Best 2023 Buys24/7 Wall Street • 04/12/23
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreementsGlobeNewsWire • 04/11/23
Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.GlobeNewsWire • 04/10/23
Press Release: Two fitusiran Phase 3 studies published in The Lancet and The Lancet Haematology highlight potential to address unmet needs across all types of hemophiliaGlobeNewsWire • 04/04/23